Edition:
United Kingdom

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

10.92USD
15 Dec 2017
Change (% chg)

$-0.20 (-1.80%)
Prev Close
$11.12
Open
$11.15
Day's High
$11.19
Day's Low
$10.75
Volume
4,403,743
Avg. Vol
980,497
52-wk High
$13.38
52-wk Low
$6.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 29.75 -0.217
FY 2017 Jun '17 33.78 -0.173
Mar '17 33.28 -0.209
Dec 44.52 -0.139
Sep 39.27 -0.197
FY 2016 Jun '16 43.21 -0.174
Mar '16 43.05 -0.158
Dec 35.43 -0.169
Sep 16.20 -0.148
FY 2015 Jun '15 12.32 -0.090
Mar '15 6.60 0.351
Dec 26.92 -0.064
Sep 6.07 -0.209
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 9 28.60 37.00 13.00 --
Quarter Ending Sep-18 2 30.36 45.00 15.73 --
Year Ending Jun-17 9 144.51 150.40 130.10 --
Year Ending Jun-18 9 109.83 170.00 63.00 143.31
Year Ending Jun-19 9 186.77 349.89 78.20 252.15
Earnings (per share)
Quarter Ending Jun-17 9 -0.21 -0.01 -0.29 --
Quarter Ending Sep-18 1 0.11 0.11 0.11 --
Year Ending Jun-17 9 -0.76 -0.56 -0.86 --
Year Ending Jun-18 9 -0.99 -0.71 -1.27 -0.77
Year Ending Jun-19 9 -0.58 0.44 -1.52 -0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. 109.04 290.77 45.62
P/E Low - Last 5 Yrs. 109.04 93.67 24.34
Beta 1.99 0.85 0.88
Price to Sales (TTM) 15.70 100.68 5.40
Price to Book (MRQ) 179.97 13.50 5.38
Price to Tangible Book (MRQ) 201.96 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 94.80 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -21.82 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago 9.41 75.04 5.38
Sales - 5 Yr. Growth Rate 12.12 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 0.60 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -10.58 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 19.62 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 3.88 5.36 2.98
LT Debt to Equity (MRQ) 1,141.85 18.93 11.56
Total Debt to Equity (MRQ) 1,141.85 20.59 15.81
Interest Coverage (TTM) -7.73 -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 76.54 38.73 54.83
Gross Margin - 5 Yr. Avg. 60.43 51.18 52.40
EBITD Margin (TTM) -66.30 -- --
EBITD - 5 Yr. Avg -61.65 -261.13 15.24
Operating Margin (TTM) -68.66 -556.69 7.76
Operating Margin - 5 Yr. Avg. -68.28 -279.31 10.75
Pre-Tax Margin (TTM) -77.44 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -76.83 -279.05 11.17
Net Profit Margin (TTM) -77.44 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -76.83 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 721,780 25,316,769 864,680,848
Net Income/Employee (TTM) -558,938 3,332,346 101,718,394
Receivable Turnover (TTM) 4.27 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.67 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.15 -0.77 11.00
Return on Assets - 5 Yr. Avg. -41.58 -0.26 12.43
Return on Investment (TTM) -71.65 2.36 14.46
Return on Investment - 5 Yr. Avg. -61.52 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.41 17.51
  1 Year 3 Year 5 Year
Sales % 9.41 53.05 12.12
EPS (TTM) % -10.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Array Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 264
Total Shares Held: 201,790,621
3 Mo. Net Change: 26,145,076
# New Positions: 47
# Closed Positions: 39
# Increased Positions: 130
# Reduced Positions: 104
# Net Buyers: 26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.